K. Hans
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
Papers in
- Oncology 20
- Lung Cancer Research Studies 20
- Peptidase Inhibition and Analysis 4
- Epidemiology 12
- Neuroendocrine Tumor Research Advances 11
- Multiple and Secondary Primary Cancers 1
- Co-authors
- M. Wolf (10 shared papers)P. Drings (10 shared papers)Rolf Holle (8 shared papers)K. Havemann (11 shared papers)Monika Serke (3 shared papers)Wolfgang Schuette (3 shared papers)Christine Lautenschlaeger (3 shared papers)S. Nagel (3 shared papers)
- Journals
- Lung Cancer (7 papers)Journal of Clinical Oncology (6 papers)European Journal of Cancer (2 papers)British Journal of Cancer (1 paper)Cancer (1 paper)
- Partner nations
- GermanyNetherlandsChina
In The Last Decade
K. Hans
21 papers receiving 574 citations
Peers
Comparison fields: 5 of 51
- Oncology 415
- Pulmonary and Respiratory Medicine 251
- Epidemiology 154
- Otorhinolaryngology 12
- Molecular Biology 88
Countries citing papers authored by K. Hans
This map shows the geographic impact of K. Hans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Hans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Hans more than expected).
Fields of papers citing papers by K. Hans
This network shows the impact of papers produced by K. Hans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Hans. The network helps show where K. Hans may publish in the future.
Co-authors
The 25 scholars most cited alongside K. Hans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 157 | |
| 2 | 1991 | 116 | |
| 3 | 1987 | 69 | |
| 4 | 1997 | 55 | |
| 5 | 1987 | 53 | |
| 6 | 1991 | 40 | |
| 7 | Radiotherapy alone versus chemotherapy with ifosfamide/vindesine followed by radiotherapy in unresectable locally advanced non-small cell lung cancer. | 1994 | 37 |
| 8 | [Ambulatory laparoscopic cholecystectomy is as effective as hospitalization and from a social perspective less expensive: a randomized study]. | 2001 | 36 |
| 9 | 1997 | 15 | |
| 10 | 2004 | 14 | |
| 11 | 1991 | 9 | |
| 12 | 1991 | 9 | |
| 13 | 2004 | 5 | |
| 14 | 1987 | 3 | |
| 15 | 2006 | 2 | |
| 16 | 1994 | 2 | |
| 17 | 2009 | 1 | |
| 18 | 2000 | 1 | |
| 19 | 1986 | 1 | |
| 20 | 2005 | 1 |
About K. Hans
K. Hans is a scholar working on Oncology, Epidemiology, Pulmonary and Respiratory Medicine, Molecular Biology and Surgery, having authored 24 papers that have together received 629 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (20 papers), Neuroendocrine Tumor Research Advances (11 papers), Lung Cancer Treatments and Mutations (8 papers), Cancer therapeutics and mechanisms (7 papers), Peptidase Inhibition and Analysis (4 papers), Lung Cancer Diagnosis and Treatment (4 papers), Multiple and Secondary Primary Cancers (1 paper) and Synthesis and Biological Activity (1 paper). The work is most often cited by research in Oncology (415 citations), Pulmonary and Respiratory Medicine (251 citations), Epidemiology (154 citations), Otorhinolaryngology (12 citations) and Molecular Biology (88 citations). K. Hans has collaborated with scholars based in Germany, Netherlands and China. Frequent co-authors include M. Wolf, P. Drings, Rolf Holle, K. Havemann, Monika Serke, Wolfgang Schuette, Christine Lautenschlaeger, S. Nagel, Manfred Heim and H Schweisfurth. Their work appears in journals such as Lung Cancer, Journal of Clinical Oncology, European Journal of Cancer, British Journal of Cancer and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.